Jeff Worthington

Biography

Jeff Worthington has served as Senopsys’ President since founding the company in 2006. He started Senopsys to build an enduring organization dedicated to improving human health and quality of life by enabling drug makers to develop palatable, patient-accepted products. Under his leadership, Senopsys has assembled a talented scientific team and built the laboratory and clinical infrastructure to support pharmaceutical taste assessment and taste masking studies. Prior to founding Senopsys, Jeff was Vice President of Food and Pharmaceutical Technology at Arthur D. Little, Inc., and its successor company TIAX, where he built an international reputation as a thought leader in taste masking directing programs for pharma, biotech and drug delivery companies. Jeff earned his BS in Chemistry from Northeastern University and MBA from Babson College. He is chair of the Applied Sensory Technology Work Group of the National Institutes of Health’s Pediatric Formulation Initiative and holds several patents related to sensory technology.

Research Interest

 Biomedical sciences, Pharmaceuticals, biotechnology and drug delivery process